BUY PHENYLJECT ONLINE

We are excited to present “PHENYLJECT,” a trusted injectable solution that offers a range of benefits for your health and well-being.

Product Name: PHENYLJECT
Product Type: Injectable Solution

Product Description:
“PHENYLJECT” is a precisely formulated injectable solution designed to provide effective relief for various conditions. This solution combines high-quality ingredients, advanced technology, and strict quality standards to ensure optimum results and safety.

Key Features and Benefits:

1. Pain Management: “PHENYLJECT” is primarily known for its exceptional pain-relieving properties. This injectable solution can help alleviate moderate to severe pain, making it a valuable option for individuals dealing with conditions such as post-operative pain, musculoskeletal pain, or other painful conditions.
2. Anti-inflammatory Action: Inflammation can cause discomfort and restrict mobility. “PHENYLJECT” contains potent anti-inflammatory agents that work to reduce swelling, inflammation, and pain associated with inflammatory conditions. By targeting the root cause of inflammation, this injectable solution can help restore your comfort and improve your mobility.
3. Rapid Onset of Action: With “PHENYLJECT,” you can expect a rapid onset of action, providing you with much-needed relief in a shorter timeframe. This allows you to manage pain effectively and resume your daily activities more comfortably.
4. Flexible Dosage Options: “PHENYLJECT” offers flexible dosage options, ensuring that you can customize the treatment according to your specific needs. This allows for personalized pain management, enhancing the effectiveness of the solution for your unique condition.
5. Quality Assurance: At Equicurepharm, we prioritize your safety and satisfaction. “PHENYLJECT” undergoes stringent quality control measures to ensure that each batch meets the highest standards of purity, potency, and sterility. We are committed to delivering a reliable and top-quality product.

Ordering and Discreet Delivery:
At Equicurepharm, we understand the importance of privacy and confidentiality. When you place an order for “PHENYLJECT,” we guarantee discreet packaging and worldwide delivery. Your order will be carefully packaged to protect the product and maintain its integrity during transit, ensuring a seamless experience from start to finish.

Please note that “PHENYLJECT” is a prescription medication and should only be used under the guidance and supervision of a healthcare professional. It is crucial to consult with a healthcare provider before administering this injectable solution to ensure the appropriate dosage and usage instructions.

Experience Relief with “PHENYLJECT” Today:
Find effective relief from pain and inflammation with “PHENYLJECT.” Place your order now and experience the trusted benefits this injectable solution has to offer. At Equicurepharm, we are committed to providing you with superior products and excellent customer service every step of the way.

Disclaimer: The information provided is for educational purposes only and should not be considered medical advice. Always consult with a healthcare professional before starting any new medication or treatment.

PHENYLJECT Solution for parenteral administration
Composition
Contains per ml:
Phenylbutazone 200 mg.
Excipients ad 1 ml.
Description
Phenylbutazone is a pyrazolone derivative belonging to the group of antipyretic analgesics with besides analgesic and antipyretic also antiflogistic properties (NSAIDs). Phenylbutazone acts by inhibiting the production of prostaglandins.
Indications
Phenylject is indicated for the treatment of musculo-skeletal disorders in horses where the antiinflammatory and analgesic properties of phenylbutazone can offer relief against inflammation, pain and lameness (e.g. osteoarthritis, acute and chronic laminitis, bursitis and carpitis).
Contra indications
The therapeutic index of phenylbutazone is low. Do not exceed the stated dose or the duration of treatment.
Do not administer with other NSAIDs concurrently or within 24 hours of each other.
Do not use in animals suffering from cardiac, hepatic or renal disease; where there is the possibility of gastrointestinal ulceration or bleeding; where there is evidence of blood dyscrasias or hypersensitivity to the product.
Use during pregnancy should be avoided whenever possible, particularly during the first trimester.

Side effects
Non-steroidal anti-inflammatory drugs can cause inhibition of phagocytosis and hence in the treatment of inflammatory conditions associated with bacterial infection, appropriate concurrent antimicrobial therapy should be instigated.
There is a risk of irritancy if the injection is accidentally inoculated under the skin during intravenous administration.
Rarely, collapse following intravenous injection has been reported. The product should be injected slowly over as long a period as is reasonably practical. At the first signs of intolerance, the administration of the injection should be interrupted.
Some non-steroidal anti-inflammatory agents may be highly bound to plasma proteins and compete with other highly bound drugs to produce an increase in non-bound pharmacologically active concentrations which can lead to toxic effects.
Gastrointestinal tract ulceration may be exacerbated by corticosteroids in animals given nonsteroidal anti-inflammatory drugs.
Concurrent administration of potential nephrotoxic drugs (e.g. aminoglycoside antibiotics) should be avoided.

Dosage
For very slow intravenous administration.

Horses: 1 ml per 45 kg (4.4 mg phenylbutazone/kg), with a maximum of 10 ml.

To be administered in a single dose, which may be followed if necessary by oral phenylbutazone therapy commencing 24 hours after the injection. In acute cases and in hospitalised animals it may be administered once daily for not more than five consecutive days. Observe aseptic conditions.

Withdrawal times
Not to be used in horses intended for human consumption.
Treated horses may never be slaughtered for human consumption.

.

Packaging
Brown type II glass bottle of 100 ml, closed with type I butylsepta and aluminium caps.
Phenylject
Horses